TY  - GEN
AU  - Salmon-Céron,Dominique
AU  - Lassalle,Régis
AU  - Pruvost,Alain
AU  - Benech,Henri
AU  - Bouvier-Alias,Magali
AU  - Payan,Christopher
AU  - Goujard,Cécile
AU  - Bonnet,Eric
AU  - Zoulim,Fabien
AU  - Morlat,Philippe
AU  - Sogni,Philippe
AU  - Pérusat,Sophie
AU  - Tréluyer,Jean-Marc
AU  - Chêne,Geneviève
TI  - Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial
SN  - 1537-6591
PY  - 2003///0610
KW  - Adult
KW  - Antiviral Agents
KW  - therapeutic use
KW  - CD4 Lymphocyte Count
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - HIV Infections
KW  - blood
KW  - HIV-1
KW  - drug effects
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Interferons
KW  - Male
KW  - Middle Aged
KW  - RNA, Viral
KW  - Ribavirin
KW  - Stavudine
KW  - pharmacokinetics
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1086/374837
ER  -